Terms: = Lymphoma AND CLTCL1, CLTCL, 8218, ENSG00000070371, P53675
5 results:
1. Real-world outcomes of AIDS-related Burkitt lymphoma: a retrospective study of 78 cases over a 10-year period.
Wang Z; Zhang R; Gong Z; Liu L; Shen Y; Chen J; Qi T; Song W; Tang Y; Sun J; Lin Y; Xu S; Yang J; Lu H
Int J Hematol; 2021 Jun; 113(6):903-909. PubMed ID: 33594656
[TBL] [Abstract] [Full Text] [Related]
2. Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.
Cools J; Wlodarska I; Somers R; Mentens N; Pedeutour F; Maes B; De Wolf-Peeters C; Pauwels P; Hagemeijer A; Marynen P
Genes Chromosomes Cancer; 2002 Aug; 34(4):354-62. PubMed ID: 12112524
[TBL] [Abstract] [Full Text] [Related]
3. Timely topic: anaplastic lymphoma kinase (ALK) spreads its influence.
Cheuk W; Chan JK
Pathology; 2001 Feb; 33(1):7-12. PubMed ID: 11280613
[TBL] [Abstract] [Full Text] [Related]
4. Risk of false positive results in comparative genomic hybridization.
Barth TF; Benner A; Bentz M; Döhner H; Möller P; Lichter P
Genes Chromosomes Cancer; 2000 Jul; 28(3):353-7. PubMed ID: 10862043
[TBL] [Abstract] [Full Text] [Related]
5. Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to cltcl (clathrin chain polypeptide-like).
Touriol C; Greenland C; Lamant L; Pulford K; Bernard F; Rousset T; Mason DY; Delsol G
Blood; 2000 May; 95(10):3204-7. PubMed ID: 10807789
[TBL] [Abstract] [Full Text] [Related]
